Rizing Tide Awards $570K in DPT Scholarships for 2025
Fifth-Year Cohort of Scholars Selected from Nearly 400 Applicants Across 20 DPT Programs Nationwide Rizing Tide, a foundation dedicated to expanding access to physical therapy care...
Category : Public Health, Disease Prevention & Wellness
Ethris Doses First Patient in Phase 2a Trial for Asthma Drug
Ethris GmbH, a clinical-stage biotechnology company pioneering next-generation RNA therapeutics and vaccines, today announced that the first patient has been treated in a Phase 2a...
EU Approves CAR-T Therapy with AGC Biologics Vectors
The Friendly CDMO Expert’s Milan Cell and Gene Center of Excellence Achieves 10th Major Regulatory Product Approval Following news on July 21 that the European Commission...
Altasciences, VoxCell Partner to Advance Drug Development
Altasciences, a fully integrated drug development solution company, and VoxCell BioInnovation (“VoxCell”), a leader in 3D bioprinting and human-like tissue modeling, are pleased to announce a strategic...
AHLA Foundation Unites Industry to Fight Human Trafficking
No Room for Trafficking Summit Focuses on Collaboration and Grant-Making to Build Awareness and Promote Prevention Efforts AHLA Foundation today convened survivors, experts and industry...
Ohana Health Plan, Partners Launch Mobile School-Based Clinic
The mobile health clinic will begin service in August for the 2025-2026 school year ‘Ohana Health Plan, a leading provider of government-sponsored managed care services...
Eviva Partners Launches Think Tank on Aluminum Vaccine Attacks
Eviva Partners, a nonprofit organization dedicated to strengthening public understanding of medical evidence, is proud to announce the launch of Protecting Our Health (POH), a new...
Tsingke Biotech Hosts 2025 Nucleic Acid Therapeutics Roundtable
Industry experts gather to explore oligonucleotide innovation, delivery strategies, and commercialization pathways Tsingke Biotech, a leading provider of synthetic biology and nucleic acid solutions, successfully...
New Campaign Teaches What to Do When Lung Nodules Are Found
American Lung Association, in partnership with Olympus, launches educational campaign based on findings from national focus groups and patient survey In honor of World Lung...
Pfizer & BioNTech Get Positive EU Opinion for COVID Vaccine
Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) announced today that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has...
Taiho & Cullinan Present Zipalertinib Data at IASLC 2025 Conference
Taiho Oncology, Inc., and Cullinan Therapeutics, Inc., today announced the presentation of new data from zipalertinib REZILIENT1 and REZILIENT2 trials at the International Association of...
30 Studies Show Significant Health Benefits of Almased
Two recent, peer-reviewed clinical studies have found that Almased, a high-protein, low-glycemic meal replacement, delivers significant health benefits ranging from weight loss and improved metabolic health...
Takeda Gets FDA Clearance for HyHub™ Devices
Takeda(TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for HyHubTM and HyHubTM Duo, devices for patients 17 years of age and...
Kihealth Wins ADA Award for Diabetes Diagnostic Innovation
Kihealth, a leader in molecular diagnostics, today announced it has won the Innovation of the Year challenge at the American Diabetes Association’s 85th Scientific Session held in Chicago....
5-Year Study Confirms Safety of Fixed-Dose Eye Drops After Surgery
A recently published five-year pharmacovigilance study confirms the excellent safety profile of a fixed-dose combination eye drop containing an anti-inflammatory steroid and a quinolone antibiotic, developed by NTC,...